Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.89
-0.09 (-1.51%)
At close: Feb 27, 2026, 4:00 PM EST
5.90
+0.01 (0.17%)
After-hours: Feb 27, 2026, 4:10 PM EST
Aura Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Aura Biosciences stock have an average target of 20.2, with a low estimate of 13 and a high estimate of 25. The average target predicts an increase of 242.95% from the current stock price of 5.89.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 26, 2025.
Analyst Ratings
The average analyst rating for Aura Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $13 | Buy | Initiates | $13 | +120.71% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +273.51% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +273.51% | May 28, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $19 | Buy | Reiterates | $19 | +222.58% | May 23, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +222.58% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.00
from -1.75
EPS Next Year
-1.89
from -2.00
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.89 | -1.79 | |
| Avg | -2.00 | -1.89 | |
| Low | -2.47 | -2.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.